SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences - Quaterly Results

10 Feb 2024 Evaluate
The sales slipped to Rs. 712.27 millions for the December 2023 quarter as against Rs. 907.57 millions during the year-ago period.A slender decline of -17.35% was recorded to Rs. 33.15  millions from Rs. 40.11 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 96.63 millions from 87.13 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 712.27 907.57 -21.52 2136.28 2496.90 -14.44 3152.42 3456.28 -8.79
Other Income 6.40 5.03 27.24 15.58 9.34 66.81 28.82 15.36 87.63
PBIDT 96.63 87.13 10.90 251.77 244.80 2.85 292.88 329.00 -10.98
Interest 20.45 12.59 62.43 63.43 36.81 72.32 50.94 46.25 10.14
PBDT 76.18 74.54 2.20 188.34 207.99 -9.45 265.46 409.67 -35.20
Depreciation 25.46 20.29 25.48 76.30 60.56 25.99 81.73 79.90 2.29
PBT 50.72 54.25 -6.51 112.04 147.43 -24.00 183.73 329.77 -44.29
TAX 17.57 14.14 24.26 40.73 39.91 2.05 51.55 75.96 -32.14
Deferred Tax 2.57 -0.86 -398.84 7.72 -2.59 -398.07 20.05 0.36 5469.44
PAT 33.15 40.11 -17.35 71.31 107.52 -33.68 132.18 253.81 -47.92
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 13.57 9.60 41.31 11.79 9.80 20.21 9.29 9.52 -2.40

Haleos Labs Share Price

1415.00 121.45 (9.39%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×